NEW 2024 edition: Care Around Stillbirth and Neonatal Death Clinical Practice Guideline available now
Our Vision
Our Vision
Our vision is to reduce the devastating impact of stillbirth for women, families and the wider community through improving care to reduce the number of stillborn babies and to reduce the impact of this loss.
People + Partners
People + Partners
Meet the network of people, organisations, and professional institutions driving research and program implementation across the Stillbirth CRE.
Our work
Our Work
Explore some of the latest Stillbirth CRE research projects, scientific studies, and educational campaigns on stillbirth prevention and care after stillbirth.
Parent STories
News + Events
News + events
View the latest news and events from the Stillbirth CRE and our collaborating partners.
Get Involved
Get Involved
There's so many ways to contribute to stillbirth research. Sign up to our newsletter to stay in touch with the latest news, join our community, make a donation, or participate in research. Find out all the ways to Get Involved.
Safer Baby in pregnancy
Care after loss
Seeking Support
Research and news

Our aim is to improve care to reduce the number of stillborn babies and to reduce the impact of this loss.
Frequently asked questions
Get Involved


Project Status In Progress
Funding Organisation Biorithm Pte Ltd, Avant Mutual Pte Ltd
Organisation Lead Monash University
Lead Investigator Vinayak Smith
Program Area New Approaches To Prevention
Topic Testing Novel Interventions To Reduce Stillbirth Rates
Contact Vinayak Smith at

Fetal heart rate monitoring (FHR) using cardiotocography (CTG) remains the most commonly used test in pregnancy in ensuring fetal well-being. However, it has several limitations such as being poor at detecting fetal compromise, being an inpatient test and requiring clinician oversight. To improve these, FEMOM, a wearable ambulatory device, has been invented to enable prescribed woman centric clinical grade FHR monitoring from home. This uses a state of the art monitoring technology called the non-invasive fetal electrocardiogram (NIFECG) which provides more clarity on how the fetus heart is functioning in contrast to routine CTG. This work aims to investigate how intensive monitoring of high-risk pregnancies, particularly those with fetal growth restriction, can aid in avoiding the devastating outcome of stillbirth. Also, it aims to redefine how pregnancy monitoring is carried out as a whole so it can be more lifestyle friendly to the 20th century woman and place more control into their hands.